about
Risk for gastric neoplasias in patients with chronic atrophic gastritis: a critical reappraisalRole of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases.Clinical aspects of ECL-cell abnormalities.Morphological, molecular, and prognostic aspects of gastric endocrine tumors.Mechanism of acid hypersecretion post curative gastrinoma resectionInvolvement of cholecystokinin/gastrin-related peptides and their receptors in clinical gastrointestinal disorders.Praomys (Mastomys) natalensis: a model for gastric carcinoid formationThe biology and pathobiology of the ECL cells.Hyperplastic proliferations of the ECL cells.Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.Pancreatic cancer: the role of cholecystokinin?Resolved and unresolved controversies in the surgical management of patients with Zollinger-Ellison syndrome.HypergastrinemiaCholecystokinin antagonists--a toxicologic perspective.Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.Classification of gastric neuroendocrine tumors and its clinicopathologic significance.Upper gastrointestinal carcinoid tumors incidentally found by endoscopic examinations.Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome.Chronic hypergastrinemia: causes and consequences.Hypergastrinemia and enterochromaffin-like cell hyperplasia.The consequences of hypergastrinemia.Zollinger-Ellison syndrome: past, present and future controversies.The biological relevance of gastric neuroendocrine tumorsCCKB/gastrin receptor antagonists: recent advances and potential uses in gastric secretory disordersAutoimmune gastritis.The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.Use of omeprazole in patients with Zollinger-Ellison syndrome.Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology.The role of gastrin and cholecystokinin in normal and neoplastic gastrointestinal growth.Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. A review and analysis.Pathogenesis and diagnosis of enterochromaffin-like cell tumors.Gastro-esophageal reflux and antisecretory drugs use among patients with chronic autoimmune atrophic gastritis: a study with pH-impedance monitoring.Inhibition of gastrin-induced proliferation of AR4-2J cells by calcium channel antagonists.Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.Insulinomas derived from hyperplastic intra-hepatic islet transplants.Prevention of relapse of reflux esophagitis after endoscopic healing: the efficacy and safety of omeprazole compared with ranitidine.Rapid induction of enterochromaffinlike cell tumors by histamine2-receptor blockadeProspective study of the ability of histamine, serotonin or serum chromogranin A levels to identify gastric carcinoids in patients with gastrinomas.Discussion: Enterochromaffin-Like Cell Pathobiology.Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial.
P2860
Q27021198-3F2A70D1-48BE-4D0E-B577-D731CA883C06Q30487910-9C5C3D4A-F881-47F3-B172-84AE9F1B11C7Q33719581-1E5D3D8C-4224-452B-A165-F4E4796B295EQ33875952-6E2CD2A4-73C2-4041-8229-7C4B9CDD35ABQ34345074-4613723A-D693-4DD9-820E-C1CE39C1202AQ35104427-E13DFF7D-9BA9-4127-B554-03446B60FE83Q35242642-60BB4E5F-D868-4285-A3DC-655FE18331EBQ35242654-30E30F73-C345-4734-B963-3AB9C5B4D24FQ35242674-FD648C8A-002B-4E54-B438-FFEADF7C22E6Q35351719-D065AC24-EA24-46F3-8615-0840D9A407DFQ35645684-3AC986AF-5010-43D3-9C0F-849462B9002BQ35922060-53AB1C35-D61C-4EC8-A52F-EBBF17BECCD4Q35923382-AE912221-67B3-4FA8-9F0B-89DEF46BB6B3Q36071597-F3E6CC6F-067D-4CC9-A8A7-E9D862A25240Q36376528-B9140719-19B5-4F26-89DB-66251AC9AAFDQ36397178-DEBEC592-1BEB-41B5-A40A-6C7C1BCFDD84Q36474518-D61749D5-7541-42D1-A060-59C1DB0A07B1Q36484987-8AB8F44A-ADA8-4760-9934-0989FBE1CC4CQ36784431-068DCF17-6B67-4E64-A581-1227B843C5C9Q36963072-03C6404B-CFDB-4675-BFB7-B2B9A424E247Q36987482-6440320F-1C0C-4EFA-A164-9CE5BB69BBDCQ36987493-C8E09C9C-8A8E-41DD-AFE4-2B54060C4E57Q36987567-4CBA4A5F-ED05-46CD-8BA6-517F3F599B00Q36987633-24C209D1-8DFB-4387-A14A-56D05DD8E0BCQ37341812-B742432F-20B2-4AD4-9E9E-06314921904BQ37650725-7E2A7A45-6F38-40E2-ABC9-614B6511DD32Q37674520-7570AC84-FB50-42AE-ABA5-FB6E5A5B67E2Q38547653-D272E842-4227-4770-B0FB-7FC494710C43Q40548301-A7521E58-C8D0-409C-A35C-353894566D02Q40595580-32A6450A-05FA-4113-892D-D8F50F1858B6Q40642441-CA495B96-3762-4F38-8D7E-66989773EC84Q41122942-0EE9067D-74F5-4D24-BBFA-6FEE626A0568Q41492869-793361D5-B41B-489C-A83D-11808EF6CE6BQ41614766-EBCA854D-FC9B-4C3E-86BA-03E0A53511BCQ42284273-FC5D817B-673C-4D07-A25A-22133EC8DDA9Q42471297-0A21630D-6A06-409B-9E37-AB3BAC0ED6F1Q42755070-6A4575E7-D7DB-4DF1-9FA3-D390A4D6F6AAQ44080567-6BEE72F2-70E8-4FF9-9540-CD43ED533FF1Q45786030-69A96098-17B3-4F15-B3A4-B1329D033770Q46946129-8414A652-83BF-4F63-B738-C9026879A1F7
P2860
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
The achlorhydria-carcinoid sequence: role of gastrin.
@en
The achlorhydria-carcinoid sequence: role of gastrin.
@nl
type
label
The achlorhydria-carcinoid sequence: role of gastrin.
@en
The achlorhydria-carcinoid sequence: role of gastrin.
@nl
prefLabel
The achlorhydria-carcinoid sequence: role of gastrin.
@en
The achlorhydria-carcinoid sequence: role of gastrin.
@nl
P356
P1433
P1476
The achlorhydria-carcinoid sequence: role of gastrin.
@en
P2093
Creutzfeldt W
P356
10.1159/000199609
P577
1988-01-01T00:00:00Z